LogicBio Therapeutics, Inc. Made Big Gain
Mon, May 09, 2022 at 05:35 PM
LogicBio Therapeutics, Inc. (LOGC:NASDAQ) shot up at $0.67, representing a gain of 34.3%. The stock got featured on our News Catalysts scanner on Mon, May 09, 2022 at 12:07 PM in the 'BIOTECH' category. From Mon, Apr 25, 2022, the stock recorded 55.56% Up Days and 50.00% Green Days
About LogicBio Therapeutics, Inc. (LOGC:NASDAQ)
LogicBio Therapeutics Inc is a genome editing company focused on developing medicines to durably treat rare diseases in patients with significant unmet medical need using GeneRide, its proprietary technology platform.
Top 10 Gainers:
- Hemisphere Media Group, Inc. (HMTV:NASDAQ), 78.78%
- Blue Water Vaccines Inc. (BWV:NASDAQ), 44.15%
- Points International Ltd. (PCOM:NASDAQ), 43.38%
- ServiceSource International, Inc. (SREV:NASDAQ), 41.67%
- LogicBio Therapeutics, Inc. (LOGC:NASDAQ), 34.35%
- Exela Technologies, Inc. (XELA:NASDAQ), 28.46%
- Society Pass Incorporated (SOPA:NASDAQ), 26.46%
- MedAvail Holdings Inc. (MDVL:NASDAQ), 26.44%
- Tenon Medical Inc. (TNON:NASDAQ), 25.09%
- Lianluo Smart Limited (LLIT:NASDAQ), 24.59%